00188-7/asset/7e57df33-1af5-4977-8ce9-e2e551a50088/main.assets/gr3_lrg.jpg)
safety of tirzepatide Efficacy and monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial fda tirzepatide approval Is tirzepatide
Description
Those with known allergies to growth hormone fragments or peptide formulations should avoid use
Clinical data from tirzepatide trials show that decreased core temperature occurs in 515% of participants, depending on dose and individual sensitivity
However, the recent inclusion of prescription drugs in their programme has raised questions about the validity of this approach
They work on the same receptor to stimulate it
